Welcoming Stephanie Kreml, M.D. as Newest Team Member

April 3rd, 2013
Posted by

I’m pleased to announce that Stephanie Kreml, M.D. has returned to Popper and Company, joining our core team of life science advisors as Principal.
Like all of our team members, Stephanie is committed to delivering perspective, value, and high-quality, hands-on service to clients across the life sciences spectrum.  As a practicing physician with an engineering background, Stephanie brings a unique multi-disciplinary perspective to helping life sciences companies address diverse healthcare issues.  She is an excellent addition to our existing team of experts whose operational backgrounds span clinical, technology, marketing and finance in a variety of capacities in the diagnostics, medical device, pharmaceuticals and digital health industries.

You can read Stephanie’s full bio here.  Please join me in welcoming her, and please do not hesitate to reach us if you have questions that Stephanie can help address, including those focused on business strategy, commercialization, diligence, and product development.  We’re excited to have Stephanie back on board, and to put our entire team of experienced industry experts to work addressing your life science company’s complex challenges.

Like this content? Don’t miss an update.

About the Author:

I founded Popper and Company with Ken Walz more than ten years ago to address inefficiencies in health care by helping life science companies develop and commercialize new technology. Today, the members of our growing team leverage their extensive knowledge of the tools and trends shaping all aspects of health care and its participants. Send me an email.